Cancer clinical trial program.
Summary
Allows an organization or entity to establish and administer a cancer clinical trial participation program for the purpose of providing payments to a participant for certain costs incurred by the participant while participating in a cancer clinical trial. Sets forth program requirements and participant eligibility.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
House Passage
Mar 2025
Senate Passage
Mar 2025
Signed into Law
Apr 2025
Introduced Jan 8, 2025
Signed Apr 3, 2025
Maddy AI version diff · 3 comparisons
What changed between versions
House Bill (S)
→
House Bill (H)
·
4 edits
MODERATE
This bill was amended and passed through the Senate, changing its status from a House Bill to an Engrossed House Bill. The primary changes involve updating dates to reflect Senate action, adding Senate sponsors to the bill text, and incorporating the Senate's favorable report. These are procedural changes that indicate the bill has been approved by both chambers and is ready for final passage.
TECHNICAL
Bill title changed from HB 1065 to EH 1065 to reflect it is now an engrossed version passed by both House and Senate.
Senate sponsors (Charbonneau, Crider, Yoder, Jackson L) added to the bill text.
House-only committee vote information removed as the bill has now passed both chambers.
TIMELINE
Dates updated to reflect Senate action including March 14, 2025 as the engrossed date and March 13, 2025 as the Senate report date.
Floor votes · Senate Mar 18, 2025 · House Feb 17, 2025
How they voted
49–0
Passed · 1 other
Total votes 50
Mar 18, 2025
D
Democratic10
100% Yea
R
Republican40
97% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
22
Key actions
8
Committee
2
Apr 3, 2025
Signed into law
Signed by the Governor
executive
Mar 27, 2025
Upper · Passed
Signed by the President of the Senate
upper
Mar 24, 2025
Upper · Passed
Signed by the President Pro Tempore
upper
Mar 20, 2025
Lower · Passed
Signed by the Speaker
lower
Mar 18, 2025
Upper · Passed
Third reading: passed; Roll Call 242: yeas 49, nays 0
upper
Mar 13, 2025
Upper · Passed
Committee report: do pass, adopted
upper
Feb 17, 2025
Lower · Passed
Third reading: passed; Roll Call 166: yeas 95, nays 0
lower
Feb 11, 2025
Lower · Passed
Committee report: amend do pass, adopted
lower
4 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1065
Scope: IN
Hi! I can help you understand HB 1065. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline